help + privacy policy + contact us + links + home
 
About APhACareerse-CommunitiesMeetingsPublicationsJoin APhA

APhA2010 Annual Meeting Washington DC

APhA CEO Blog

APhA 
Foundation



2010 International Pharmaceutical Federation PSWC and AAPS Annual 
Meeting

Print this page

Antivirals good option in many cases, says CDC

Severity and duration of influenza illness can be reduced by antiviral medications.

An information sheet for clinicians on using antiviral medications for the treatment of 2009 H1N1 influenza has been released by CDC. The following important information is included in the single-page document to clarify common misconceptions about the timing and appropriate prescribing of antiviral medications for H1N1 influenza:

  • Although antiviral treatment is most effective when started within 48 hours of influenza illness onset, patients still benefit when treatment is started with oseltamivir more than 48 hours after illness onset.
  • Many 2009 H1N1 patients, including those with risk factors for severe illness and those who appear to be getting worse, can benefit from antiviral treatment.
  • Not having any risk factors does not mean that antiviral treatment is unnecessary.
  • Don’t wait until laboratory confirmation to start treatment—if influenza is suspected and antiviral treatment warranted, then treat even if the rapid test is negative.
  • Although pediatric oseltamivir suspension is in short supply, alternative/viable options are available. For example, children's oseltamivir capsules can be mixed with syrup at home and pharmacies can compound adult oseltamivir capsules into a suspension for treating infants and children. Additional information on compounding is available here.

Influenza antiviral medications can reduce the severity and duration of influenza illness, as well as the risk of influenza-related complications, including severe illness and death. Pharmacists are encouraged to share this information.

A new widget, 5 in 5: Clinician quick facts for 2009 H1N1, has been released by CDC. The application provides quick facts for health providers and clinicians to consider when evaluating a patient for antiviral treatment, highlighting the importance of early treatment and antiviral use after 48 hours, in the moderately ill, and in adults and children without risk factors. The widget allows content to be displayed directly on a webpage; users can embed the content in personalized homepages, blogs, and other sites. No technical maintenance is required after the widget has been added; CDC will update content automatically. To include the widget, cut and paste the html code into your webpage. If you have questions or need help adding the widget, contact CDC's Web team at cdcweb@cdc.gov.

Source

Posted by Joe Sheffer (jsheffer@aphanet.org)
November 11, 2009



Related Files
QuickFactsforCliniciansonAntiviralTreatmentsforH1N1 (Adobe PDF File)